D-(-)-Tert-butyl tert-leucinate → Tert-butyl 2-[[5-cyclopropyl-4-(2,2,2-trifluoroethoxy)pyridine-2-carbonyl]amino]-3,3-dimethyl-butanoate

HRID 1480265

Reaktionsgleichung

Reaktionsgleichung von HRID 1480265
[CH:1]1([C:4]2[C:5]([O:13][CH2:14][C:15]([F:18])([F:17])[F:16])=[CH:6][C:7]([C:10]([OH:12])=O)=[N:8][CH:9]=2)[CH2:3][CH2:2]1.[C:19]([O:23][C:24](=[O:31])[CH:25]([NH2:30])[C:26]([CH3:29])([CH3:28])[CH3:27])([CH3:22])([CH3:21])[CH3:20]>>[CH:1]1([C:4]2[C:5]([O:13][CH2:14][C:15]([F:18])([F:17])[F:16])=[CH:6][C:7]([C:10]([NH:30][CH:25]([C:26]([CH3:29])([CH3:28])[CH3:27])[C:24]([O:23][C:19]([CH3:21])([CH3:20])[CH3:22])=[O:31])=[O:12])=[N:8][CH:9]=2)[CH2:2][CH2:3]1

Komponenten

3

Versuchsvorschrift

The title compound was synthesized in analogy to Example 112e, using 5-Cyclopropyl-4-(2,2,2-trifluoro-ethoxy)-pyridine-2-carboxylic acid (Example 48c) and 2-Amino-3,3-dimethyl-butyric acid tert-butyl ester (CAN 99285-38-8) as starting materials and isolated (490 mg, 92%); MS (ESI, m/z): 431.6 (M+H+).

Aufarbeitung

  1. customisolated (490 mg, 92%)

Quellen und Nachweise

ORD-Eintrag
ord-1fe1f5af62a44c1ca561a895c1511f76
Quelldatensatz
uspto-grants-2016_08
Patentnummer
US09409866B2

Verknüpfte Notizen

Wird geladen…